Ardelyx dialysis drug approved by FDA after appeal

The U.S. Food and Drug Administration has given the green light to a Waltham biotech's dialysis drug, just over two years after initially rejecting it.

Previous Lucid's stock fell 5% after its production slumped
Next Big regional bank to close Clayton branch in early 2024